Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 300, Issue 3, pp 217–226 | Cite as

Lipophilicity and brain disposition of clonidine and structurally related imidazolidines

  • P. B. M. W. M. Timmermans
  • A. Brands
  • P. A. van Zwieten
Article

Summary

The apparent partition coefficients (P′) of clonidine and 27 of its structurally related imidazolidines were determined in the octanol/buffer (pH=7.4) system as a measure of lipophilic behaviour. Lipophilicity of the imidazolidines is limited to the free bases and the principle of additivity is valid for this series of structurally similar compounds.

Brain concentrations of clonidine and a number of its derivatives, achieved at the moment of maximal decrease in blood pressure, were determined following intravenous administration to anaesthetized rats. These brain concentrations represent the maximally attainable values. The ratio of log brain concentration/ dose administered intravenously, log (Cbrain/Ci.v.), was employed as a measure of the penetration ability of the imidazolidines into the brain. The octanol/buffer (pH=7.4) system proved a satisfactory reference model in order to describe the transport process of the present imidazolidines from the blood to the brain. The penetration ability of these compounds into the brain could be expressed mathematically by a highly significant, parabolic relationship in log P′. Ideal lipophilic character for optimal brain concentrations is connected with a log P′ value of 2.16.

Key words

Clonidine Clonidine-like imidazolidines Lipophilicity Brain disposition 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Draper, N. R., Smith, H.: Applied regression analysis. New York: Wiley 1966Google Scholar
  2. Fujita, T., Iwasa, J., Hansch, C.: A new substituent constant, π, derived from partition coefficients. J. Am. Chem. Soc. 86, 5175–5180 (1964)Google Scholar
  3. Hansch, C.: Quantitative structure-activity relationship in drug design. In: Drug design (Ariëns, E. J., ed.), vol. 1, pp. 271–342. New York: Academic Press 1971Google Scholar
  4. Hansch, C.: Quantitative approaches to pharmacological structure-activity relationships. In: Structure-activity relationship (Cavallito, C. J., ed.), vol. 1, pp. 75–165. New York: Pergamon Press 1973Google Scholar
  5. Hansch, C., Anderson, S. M.: The effect of intramolecular hydrophobic bonding on partition coefficients. J. Org. Chem. 32, 2583–2586 (1967)Google Scholar
  6. Hansch, C., Fujita, T.: ϱ-σ-π Analysis: A method for the correlation of biological activity and chemical structure. J. Am. Chem. Soc. 86, 1616–1626 (1964)Google Scholar
  7. Hansch, C., Muir, R. M., Fujita, T., Mahoney, P. P., Geiger, F., Streich, M.: The correlation of biological activity of plant growth regulators and chloromycetin derivatives with Hammett constants and partition coefficients. J. Am. Chem. Soc. 85, 2817–2824 (1963)Google Scholar
  8. Hartigan, M. J., Purcel, J. E., Novotny, M., McConnell, M. L., Lee, M.: Analytical performance of a novel nitrogen-sensitive detector and its applications with open glass tubular columns. J. Chromatogr. 99, 339–348 (1974)Google Scholar
  9. Kobinger, W.: Pharmacological basis of the cardiovascular actions of clonidine. In: Hypertension: Mechanisms and managament (Onesti, G., Kim, K. E., Moyer, J. H., eds.), pp. 369–380. New York: Grune and Stratton Inc. 1973Google Scholar
  10. Kobinger, W.: Central cardiovascular actions of clonidine. In: Central action of drugs in blood pressure regulation (Davies, D. S., Reid, J. L., eds.), p. 181. Tunbridge Wells, Kent: Pitman Medical Publishing Co. Ltd. 1975Google Scholar
  11. Kolb, B., Linder, M., Kempken, B.: The thermionic phosphorus-nitrogen detector (PND). Appl. Chromatogr. No. 21 E, 1–11 (1974)Google Scholar
  12. Lien, E. J.: Chemical structure and drug absorption. In: “Proceedings 4th Int. Symp. on Medicinal Chemistry” (Maas, J., ed.), pp. 319–342. Amsterdam: Elsevier 1974Google Scholar
  13. Nys, G. G., Rekker, R. F.: Statistical analysis of a series of partition coefficients with special reference to the predictability of folding of drug molecules. Introduction of hydrophobic fragmental constants (f-values). Chim. Thérap. 8, 521–535 (1973)Google Scholar
  14. Nys, G. G., Rekker, R. F.: The concept of hydrophobic fragmental constants (f-values) II. Extension to its applicability to the calculation of lipophilicities of aromatic and heteroaromatic structures. Eur. J. Med. Chem.-Chim. Ther. 9, 361–375 (1974)Google Scholar
  15. Purcell, W. P., Bass, G. E., Clayton, J. M.: Strategy of drug design: A molecular guide to biological activity. New York: Wiley-Interscience 1973Google Scholar
  16. Schmitt, H.: Actions des alpha-sympathomimétiques sur les structures nerveuses. Actual. Pharmacol. (Paris) 24, 93–131 (1971)Google Scholar
  17. Timmermans, P. B. M. W. M.: Clonidine (Catapresan®) and structurally related imidazolidines. Central hypotensive and antihypertensive activities; a structure-activity relationship study. Ph. D. Thesis, University of Amsterdam, The Netherlands 1976Google Scholar
  18. Timmermans, P. B. M. W. M., Zwieten, P. A. van: Dissociation constants of clonidine and structurally related imidazolidines. Arzneim. Forsch. (Drug Res.) in press (1977)Google Scholar
  19. Timmermans, P. B. M. W. M., Brands, A., Zwieten, P. A. van: Gasliquid chromatographic determination of clonidine and some analogues in rat brain tissue; brain concentrations and hypotensive activity. J. Chromatogr. (in press, 1977a)Google Scholar
  20. Timmermans, P. B. M. W. M., Zwieten, P. A. van, Speckamp, W. N.: 2-(Arylimino)imidazolidines; synthesis and hypotensive activity. Rec. Trav. Chim. Pays-Bas (in press, 1977b)Google Scholar
  21. Zwieten, P. A. van: The central action of antihypertensive drugs, mediated via central alpha-receptors. J. Pharm. Pharmacol 25, 89–95 (1973)Google Scholar
  22. Zwieten, P. A. van: Antihypertensive drugs with a central action. Prog. Pharmacol. 1, 1–63 (1975)Google Scholar

Copyright information

© Springer-Verlag 1977

Authors and Affiliations

  • P. B. M. W. M. Timmermans
    • 1
  • A. Brands
    • 1
  • P. A. van Zwieten
    • 1
  1. 1.Department of Pharmacy, Division of PharmacotherapyUniversity of AmsterdamAmsterdamThe Netherlands

Personalised recommendations